Guggenheim Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-22,082
| Closed | -$1.66M | – | 2091 |
|
|
2022
Q2 | $1.66M | Buy |
22,082
+9,775
| +79% | +$735K | 0.01% | 971 |
|
|
2022
Q1 | $330K | Buy |
12,307
+504
| +4% | +$13.5K | ﹤0.01% | 1831 |
|
|
2021
Q4 | $563K | Buy |
11,803
+1,015
| +9% | +$48.4K | ﹤0.01% | 1640 |
|
|
2021
Q3 | $717K | Buy |
10,788
+1,505
| +16% | +$100K | ﹤0.01% | 1584 |
|
|
2021
Q2 | $724K | Buy |
9,283
+1,217
| +15% | +$94.9K | ﹤0.01% | 1653 |
|
|
2021
Q1 | $763K | Buy |
8,066
+3,846
| +91% | +$364K | 0.01% | 1519 |
|
|
2020
Q4 | $514K | Buy |
+4,220
| New | +$514K | ﹤0.01% | 1629 |
|